Plain-English translation of NCT06027242 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether glutamine, a naturally occurring amino acid, can help people recover better after surgery to remove a cancerous stomach. Half of the participants will receive glutamine mixed with a filler powder, while the other half will receive only the filler powder (placebo) for 28 days after surgery. Researchers want to see if this medication improves physical recovery, muscle strength, and overall health outcomes.
After major stomach surgery, patients often struggle with nutrition, weakness, and slow recovery. This medication may help the body heal faster and maintain strength during the critical recovery period, but doctors need to test whether it actually works.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either glutamine or placebo powder mixed with food or feeding tube nutrition for 28 days after your stomach surgery. You'll wear a smartwatch to track your daily steps, and have CT scans and blood tests taken before surgery and 90 days after surgery to measure your recovery. Your participation will last about 3 months from surgery.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Taiwan
National Taiwan University Hospital
Enrollment target
~120 participants
Started
February 2023
Primary completion
August 2026
Age range
20 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jin-Ming Wu, MD
National Taiwan University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.